Patents Examined by Carolyn L Greene
  • Patent number: 11970736
    Abstract: The present disclosure relates to a next generation DNA sequencing method and use for accurate and massively parallel quantification of one or more nucleic acid targets, for example in large volumes of unpurified sample material. More particularly, the disclosed embodiments is related to a method and a kit comprising probes for detecting and quantifying genetic targets in complex samples. The disclosed embodiments includes two target-specific nucleic acid probes per genetic target, a barcode loop oligo and a bridge oligo or bridge oligo complex.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: April 30, 2024
    Assignee: Genomill Health Oy
    Inventors: Juha-Pekka Pursiheimo, Tatu Hirvonen, Anttoni Korkiakoski, Manu Tamminen
  • Patent number: 11939630
    Abstract: Disclosed is a fluorescent PCR method for detecting HLA-B*15:02 allele and a specific primer probe combination. In the present disclosure, a set of primers and probes are designed based on an HLA-B*15:02 specific SNP gene locus by using TaqMan probe technology, combining another set of primers and probes corresponding to the internal reference gene ?-Actin, and a set of primer probe for non-HLA-B*15:02 genes are designed to detect whether a DNA sample contains an HLA-B*15:02 gene and whether a sample is homozygous or heterozygous. Compared with the similar detection methods in the past, the technical scheme in the present disclosure inherits the advantages of high specificity, high throughput, high resolution, low cost, simple and convenient operation, process controllability and the like of the fluorescent PCR, and may detect whether a sample is homozygous or heterozygous.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: March 26, 2024
    Assignee: Shaanxi Lifegen Co., Ltd.
    Inventors: Penggao Dai, Zihua Zhong, Hao Wang, Zhiye Cai, Lei Meng, Le Wang
  • Patent number: 11932905
    Abstract: Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: March 19, 2024
    Assignee: Singular Genomics Systems, Inc.
    Inventors: Ryan Shultzaberger, Allen Lipson, Daan Witters
  • Patent number: 11905554
    Abstract: A sequencing primer set comprising a universal upstream primer, a universal downstream primer and a downstream primer in rich of promoter; wherein the universal upstream primer has a sequence of: 5?-TBarcodeCAAAXXXXNNN-3?; the universal downstream primer has a sequence of: 5?-GACTGCGTACGZZZZNNN-3?(SEQ ID No. 9); the downstream primer in rich of promoter has a sequence of: 5?-GACTGCGTACYYNCTATA-3?(SEQ ID No. 7).
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: February 20, 2024
    Inventors: Zhiqiang Xia, Meiling Zou, Wenquan Wang
  • Patent number: 11898199
    Abstract: The present disclosure provides, among other things, methods of screening for colorectal cancer, methods of screening for advanced adenoma, methods of screening for the presence of either colorectal cancer or advanced adenoma (or both), and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer and/or advanced adenoma screening that includes analysis of methylation status of one or more methylation biomarkers, and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer and/or advanced adenoma screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA. In various embodiments, the present disclosure provides methods for colorectal cancer and/or advanced adenoma screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA, using MSRE-qPCR.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: February 13, 2024
    Assignee: Universal Diagnostics, S.A.
    Inventors: Marko Bitenc, Kristi Kruusmaa, Juan Martinez-Barea, Christian Hense, Marko Chersicola, Primo{hacek over (z)} Knap
  • Patent number: 11884981
    Abstract: One aspect of the invention is a method for amplifying alpha globin genes HBA1, HBA2 and HBA12 in a single PCR tube to determine an HBA genotype of a subject. This method employs five primers selected to accurate and sensitively identify the HBA1, HBA2, and HBA12, a gene found at a higher frequency in citizens of Saudi Arabia, by accurately annealing to nucleic acids in a biological sample and simultaneously amplifying sequences encoding the alpha globin genes. This invention includes a procedure and required reagents for the amplification of alpha globin genes in a single PCR tube.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: January 30, 2024
    Assignee: Imam Abdulrahman Bin Faisal University
    Inventors: J. Francis Borgio, Sayed Abdulazeez, Fahd A. Al-Muhanna, Amein Kadhem Al-Ali
  • Patent number: 11873535
    Abstract: Described herein are methods and kits for authentication of botanical DNA fragments isolated from processed botanical products, including dietary supplements or nutraceutical compositions including botanical extracts.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: January 16, 2024
    Assignee: HERBALIFE INTERNATIONAL OF AMERICA, INC.
    Inventors: Zhengfei Lu, Silva Babajanian, Yanjun Zhang, Peter Chang, Gary Swanson, Maria Rubinsky
  • Patent number: 11859244
    Abstract: Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: January 2, 2024
    Assignee: Singular Genomics Systems, Inc.
    Inventors: Ryan Shultzaberger, Allen Lipson, Daan Witters
  • Patent number: 11827926
    Abstract: Described herein are methods and compositions related to the diagnosis and treatment of COVID 19 and the detection of SARS-Cov-2.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: November 28, 2023
    Inventors: Constance L. Cepko, Brian Anthony Rabe
  • Patent number: 11827944
    Abstract: Provided herein is an antibiotic susceptibility test and related compositions, methods and systems based on detection of a nucleic acid from a target microorganism in a sample in the presence or absence of a lysis treatment of the sample.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: November 28, 2023
    Assignee: CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Rustem F. Ismagilov, Emily S. Savela, Nathan Schoepp, Eric J. Liaw
  • Patent number: 11821028
    Abstract: The present disclosure provides methods, sets of substantially complementary double-stranded adapters, and kits for performing nucleic acid sequencing. The substantial complementary double-stranded adapters comprise fully complementary molecular tag regions but one or more mismatches in other regions. Such adapters are ligated to double-stranded target nucleic acids, the obtained ligation products are amplified, and the generated amplification products are sequenced. The methods according to the present disclosure allow both strands of double-stranded target nucleic acids to be sequenced from one end of the target nucleic acids.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: November 21, 2023
    Assignee: QIAGEN Sciences, LLP
    Inventor: Yexun Wang
  • Patent number: 11821040
    Abstract: The invention provides in vitro methods of determining whether an individual has a pre-cancer or cancer comprising determining the presence or absence of one or more methylation markers of a methylation marker set in a urine sample of said individual; and determining whether the individual has pre-cancer or cancer based on the detection of the presence or absence of said one or more methylation markers in the urine sample, wherein the presence of said one or more methylation markers indicates that the individual has pre-cancer or cancer. The invention further provides methods for typing pre-cancer or cancer based on the the presence or absence of one or more methylation markers of a methylation marker set in a urine sample.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: November 21, 2023
    Assignee: Nanomed Diagnostics BV
    Inventors: Willem Frederik Rurup, Loes Irene Segerink, Roderik Adriaan Kraaijenhagen, Herbert Michael Pinedo, Albert Van Den Berg, Renske Daniëla Maria Steenbergen, Jacobus Adrianus Nieuwenhuijzen, Idris Bahce, Geert Kazemier
  • Patent number: 11802307
    Abstract: Disclosed herein, inter alia, are polynucleotides, supports, kits, and methods of use thereof for amplifying, immobilizing, and sequencing polynucleotides.
    Type: Grant
    Filed: March 17, 2023
    Date of Patent: October 31, 2023
    Assignee: Singular Genomics Systems, Inc.
    Inventors: Ryan Shultzaberger, Allen Lipson, Daan Witters
  • Patent number: 11795514
    Abstract: The invention relates to an isothermal-based dual functional oligonucleotide containing quencher and reporter dye for an isothermal nucleic acid amplification and a method for nucleic acid amplification and measurement using the same. The present invention is directed to a method capable of obviating the need for an additional oligonucleotide, in addition to four to six types of oligonucleotides for a nucleic acid amplification reaction of LAMP, detecting the amount of fluorescence according to the amplification of the nucleic acid of target gene—specific sequence for DNA and RNA, enabling the detection also after the completion of the reaction, and detecting the amount of fluorescence in real-time. Therefore, the present invention allows simultaneous multiple tests by measuring the amount of fluorescence in one tube after the completion of the reaction or in real time while varying the reporter dye according to the target gene.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: October 24, 2023
    Assignee: SD BIOSENSOR, INC.
    Inventors: Yoo Deok Won, Hae Joon Park, Hyo Jin Seong, Mi Ae Lim, Sun Young Lee
  • Patent number: 11788119
    Abstract: Multiplexed methods of detecting an analyte in a sample using two or more padlock probes each specific to a different target sequence are described. The target sequence is either part of an analyte or indicative of the presence of an analyte in the sample. Each padlock probe includes an analyte-specific reporter sequence, and either a restriction cleavage site located 3? of the analyte-specific reporter sequence, and/or a first amplification primer binding site for an amplification reaction. Where the padlock probe includes a restriction cleavage site, cleavage at the restriction cleavage site occurs 3? of the analyte-specific reporter sequence. Where the padlock probe includes a first amplification primer binding site for the further amplification reaction, it does not contain a second amplification primer binding site 5? of the analyte-specific reporter sequence. Panels of probes and kits for the same are also described.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: October 17, 2023
    Assignee: Q-Linea AB
    Inventors: Camilla Russel, Jenny Goransson, Mats Gullberg
  • Patent number: 11788129
    Abstract: A GAPDH nucleic acid detection kit includes a primer set for detecting GAPDH nucleic acid. The primer set for detecting GAPDH nucleic acid includes a forward inner primer for GAPDH nucleic acids, a forward outer primer for GAPDH nucleic acids, a backward inner primer for GAPDH nucleic acids and a backward outer primer for GAPDH nucleic acids. The primer set for detecting GAPDH nucleic acid is used in a loop-mediated isothermal amplification (LAMP).
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: October 17, 2023
    Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Min-Yuan Chou, Kuang-Chi Cheng, Ming-Hua Yang, Jiun-Lin Guo
  • Patent number: 11786906
    Abstract: System, heaters, and heat transfer devices are disclosed. For example, a system for performing polymerase chain reaction includes a support member configured to receive a sample vessel and a heater that is positioned to affect a temperature of the sample vessel. The system additionally includes a heat transfer device disposed between the heater and the sample vessel. The heat transfer device illustratively includes anisotropic fibers axially aligned parallel to one another and positioned to conduct heat from the at least one heater toward the sample vessel in the axial direction of the anisotropic fibers. An exemplary heater includes a body defining one or more channels, a heating element positioned in the one or more channels, and retention members adjacent the one or more channels. At least a portion of the heating element is mechanically interlocked with the channel by deforming the retention members into a closed position.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: October 17, 2023
    Assignee: Biofire Defense, LLC
    Inventors: David E. Jones, Michael Bills, Aaron D. Wernerehl, Anson Cole Chamberlain
  • Patent number: 11781175
    Abstract: We propose a method of generating an epigenetic age prediction. The method includes providing a sample extraction test kit, and receiving a sample extracted by the sample extraction test kit. The method further includes extracting DNA from the sample and processing the DNA to receive processed DNA. The method further includes amplifying a plurality of loci in the processed DNA to receive amplified DNA and processing the amplified DNA to receive a plurality of methylation values for one or more CpG sites in the plurality of loci.
    Type: Grant
    Filed: June 2, 2022
    Date of Patent: October 10, 2023
    Assignee: H42, INC.
    Inventors: Sandra Ann R Steyaert, Geert Trooskens, Wim Maria R. Van Criekinge, Adriaan Verhelle, Johan Irma H. Vandersmissen
  • Patent number: 11783918
    Abstract: Techniques for random access of particular DNA strands from a mixture of DNA strands are described. DNA strands that encode pieces of the same digital file are labeled with the same identification sequence. The identification sequence is used to selectively separate DNA strands that contain portions of the same digital file from other DNA strands. A DNA staple positions DNA strands with the identification sequence adjacent to sequencing adaptors. DNA ligase joins the molecules to create a longer molecule with the region encoding the digital file flanked by sequencing adaptors. DNA strands that include sequencing adaptors are sequenced and the sequence data is available for further analysis. DNA strands without the identification sequence are not joined to sequencing adaptors, and thus, are not sequenced. As a result, the sequencing data produced by the DNA sequencer comes from those DNA strands that included the identification sequence.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: October 10, 2023
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Karin Strauss, Yuan-Jyue Chen
  • Patent number: 11781169
    Abstract: One or more enzymes are used to repair damage in synthetic DNA molecules that encode digital information. The enzymes are included in a repair mixture containing one or more of DNA polymerase, DNA ligase, T4 Endonuclease, Endonuclease IV, Endonuclease VIII, and uracil glycosylase. The repair mixture may also contain one or more of a buffering solution, oxidized nicotinamide adenine dinucleotide (NAD+), and deoxyribose nucleoside triphosphates (dNTPs). The synthetic DNA molecules are incubated with the repair mixture for approximately four hours. Use of the repair solution allows recovery of the digital information from damaged DNA molecules.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: October 10, 2023
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Robert N. Grass, Alexander Xavier Christof Kohll, Weida Chen